Prestige Consumer Healthcare (PBH) Non-Current Assets (2011 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Non-Current Assets came in at $3.1 billion in Q4 2025, up 3.69% year-on-year from $3.0 billion in Q4 2024, and up 3.95% quarter-over-quarter from $2.9 billion in Q3 2025.

Prestige Consumer Healthcare (PBH) Non-Current Assets (2011 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Non-Current Assets history runs 15 years deep, the most recent figure standing at $3.1 billion for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 3.69% year-over-year to $3.1 billion in Q4 2025; TTM through Dec 2025 was $11.9 billion, a 1.19% increase from a year earlier, with the FY2025 full-year figure at $3.0 billion, changed 0.36% from the prior year.
  • Non-Current Assets advanced to $3.1 billion in Q4 2025 per PBH's latest filing, from $2.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $3.4 billion in Q4 2021 and bottomed at $2.9 billion in Q3 2024.
  • The 5-year median for Non-Current Assets is $3.0 billion (2023), against an average of $3.1 billion.
  • Across the five-year window, Non-Current Assets climbed 6.9% in 2022 and declined 12.3% in 2023, its largest moves.
  • Year by year, Non-Current Assets stood at $3.4 billion in 2021, then dropped by 1.28% to $3.3 billion in 2022, then dropped by 11.82% to $2.9 billion in 2023, then advanced by 0.22% to $3.0 billion in 2024, then increased by 3.69% to $3.1 billion in 2025.
  • Per Business Quant, the three latest PBH Non-Current Assets figures stand at $3.1 billion (Q4 2025), $2.9 billion (Q3 2025), and $3.0 billion (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn 3.06 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.06 Bn
Sep 30, 2025 2.94 Bn
Jun 30, 2025 2.95 Bn
Mar 31, 2025 2.95 Bn
Dec 31, 2024 2.95 Bn
Sep 30, 2024 2.94 Bn
Jun 30, 2024 2.94 Bn
Mar 31, 2024 2.94 Bn
Dec 31, 2023 2.95 Bn
Sep 30, 2023 2.94 Bn
Jun 30, 2023 2.95 Bn
Mar 31, 2023 2.96 Bn
Dec 31, 2022 3.34 Bn
Sep 30, 2022 3.34 Bn
Jun 30, 2022 3.36 Bn
Mar 31, 2022 3.38 Bn
Dec 31, 2021 3.38 Bn
Sep 30, 2021 3.37 Bn
Jun 30, 2021 3.15 Bn
Mar 31, 2021 3.16 Bn